Clinical Trials | May 07, 2026
GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD
This is an exciting and meaningful milestone for GRIN Therapeutics
This is an exciting and meaningful milestone for GRIN Therapeutics
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
Esprit is a multicenter, randomized, placebo-controlled, double-blind study assessing the safety, pharmacodynamics, and preliminary efficacy of S-606001 as a substrate reduction therapy
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
DiaMedica said it plans to launch the trial later in 2026
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
CystoSmart, an AI tool designed to detect bladder tumors during screening and surveillance cystoscopy, is brand-agnostic and works with flexible, rigid, and single-use scopes
Subscribe To Our Newsletter & Stay Updated
